Diabetics enrolled in certain drug benefits plans through Cigna and Express Scripts could see their out-of-pocket costs for insulin capped at $25 per month, according to an April 3 announcement. But one diabetes advocate called the move "a stopgap at best" and said it doesn't address the larger issue of sky-high list prices.

The federal mandate that went into effect Jan. 1 requiring hospitals to post prices of their services online isn’t doing much good, according to the authors of an opinion piece published in the Annals of Internal Medicine.

In a first step to develop a set of AI-specific rules and regulations, the FDA released a discussion paper April 3 detailing how it plans to vet and approve AI medical devices without compromising quality or patient safety.

Two United Nations agencies have joined forces to create the Focus Group on Artificial Intelligence for Health (FG-AI4H)—a group of global representatives the UN hopes will help shape a streamlined, transparent process for vetting AI technologies in the healthcare space.

Volpara Solutions, the New Zealand-based breast imaging technology company, announced that GE Healthcare will now be distributing its VolparaDensity software for breast density assessments throughout the world.

CMS has launched an AI challenge that’s incentivizing innovators to develop solutions for a range of administrative challenges, like predicting unplanned hospital admissions and adverse events, the agency announced March 27.

CMS has proposed an update to its national coverage policy for transcatheter aortic valve replacement (TAVR), which would require hospitals to perform 50 aortic valve replacements each year to maintain a TAVR program—including at least 20 TAVRs.

The global MRI market is expected to grow to $7.5 billion by 2025, according to recent projections, up from $5.9 billion in 2017.